Illustration of a clinic building (not a photo of Temple Faculty Anesthesiology Associates)
Illustration

Christopher Cann, MD

Medical Oncology in Philadelphia, PA

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • Offers telehealth
  • 9 years since graduation
  • Public record — not managed by the clinician

About Dr. Christopher Cann

Dr. Christopher Cann is a physician specializing in medical oncology practicing in Philadelphia, PA, a graduate of Temple University School of Medicine (2017). Records list 2 practice addresses. Affiliated with Hospital of the Fox Chase Cancer Center, Temple University Hospital. Treated 101 Medicare patients in 2024.

Provider details

SpecialtyMedical OncologyOther medical oncology doctors in Philadelphia
CredentialsMD
EducationTemple University School of Medicine, 2017CMS Doctors and Clinicians
GenderMale
NPI number1124552898National Provider Identifier (CMS NPPES), issued April 2017
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Dr. Christopher Cann's specialties and state licenses

  • Hematology & Oncology Primary
    License: PA MD481183

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Christopher Cann practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Christopher Cann

  • Hospital of the Fox Chase Cancer CenterHospital · Philadelphia, PA
  • Temple University HospitalHospital · Philadelphia, PA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Christopher Cann's Medicare quality score (MIPS 2024)

81.2/100final MIPS score
49.7quality
100promoting interoperability
40improvement activities
74.2cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Dr. Christopher Cann's Medicare patients and services (2024)

101Medicare patients
308services billed
72average patient age
40%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more113$102.16
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more97$142.44
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more37$183.77
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or25$31.62

Common conditions among these patients

  • High blood pressure75%
  • High cholesterol67%
  • Cancer50%
  • Diabetes47%
  • Ischemic heart disease43%
  • Arthritis41%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Christopher Cann (2025)

$3,437.71 in 13 general payments reported in 2025.

TypePaymentsAmount
Consulting fees2$2,759
Food and beverage11$678.71

Paying companies: Taiho Oncology, Inc. ($2,264), Regeneron Pharmaceuticals, Inc. ($659), AstraZeneca Pharmaceuticals LP ($290.52), EISAI INC. ($105.97), Gilead Sciences, Inc. ($37.78), Ipsen Biopharmaceuticals, Inc ($24.77).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Temple Faculty Anesthesiology Associates

Questions about Dr. Christopher Cann

What kind of clinician is Dr. Christopher Cann?

Dr. Christopher Cann is listed as a physician specializing in medical oncology.

Where does Dr. Christopher Cann practice?

Temple Faculty Anesthesiology Associates at 3401 N Broad St, Philadelphia, PA 19140, and 1 other address in the records.

What is the office phone number for Dr. Christopher Cann?

The listed office number is (215) 707-1407. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Christopher Cann?

The National Provider Identifier is 1124552898.

Does Dr. Christopher Cann accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Christopher Cann affiliated with?

Hospital of the Fox Chase Cancer Center, Temple University Hospital.

Where did Dr. Christopher Cann go to medical school?

Temple University School of Medicine, graduating in 2017.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2024-01-29
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Call Temple Faculty Anesthesiology Associates at (215) 707-1407 or visit the clinic page to check availability.

Call now
0 clinics selected Compare